What is it about?

Background: Deltamethrin (DLM) is a broad-spectrum synthetic dibromo-pyrethroid pesticide that is widely used for agricultural and veterinary purposes. However, human exposure to the pesticide leads to neurotoxicity. Glutamine is one of the principal, free intracellular amino acids and may also be an antioxidant. This study was undertaken in order to examine the neuroprotective and antioxidant potential of L-glutamine against DLM toxicity in female Wistar albino rats. Materials and methods: The rats were divided into the following groups (n=10): Group I: control (distilled water; 10 mL/kg, po one dose), Group II: L-glutamine (1.5 g/kg, po one dose), Group III: DLM (35 mg/kg, po one dose), and Group IV: DLM (35 mg/kg, po one dose) and L-glutamine (1.5 g/kg, po one dose after 4 hours). Total oxidant status (TOS), total antioxidant status (TAS), tumor necrosis factor-α, interleukin (IL)-1β, and IL-6 levels and apoptosis were evaluated in brain tissue. Results: DLM-treated animals had a significant increase in brain biochemical parameters, as well as TOS and TAS. Furthermore, the histopathological examination showed neuronal cell degeneration in the cerebral tissue. L-Glutamine treatment decreased the elevated brain levels of TOS and neuronal cell degeneration. There was no difference in tumor necrosis factor-α, IL-1β, and IL-6 levels between the groups. Conclusion: L-Glutamine may reduce the toxic effects of DLM in the cerebral tissue through antioxidant properties. Keywords: deltamethrin, L-glutamine, rat

Featured Image

Why is it important?

Glutamine is one of the principal, free intracellular amino acids as well as may have been antioxidant and neuroprotective effect..

Perspectives

Our results demonstrate that l-glutamine has an effect on the antioxidants in the damaged brain tissue following DLM toxicity.

Dr Aslihan OKAN IBILOGLU
Dicle university Medicine Faculty Department of Psychiatry

Read the Original

This page is a summary of: Protective effects of L-glutamine against toxicity of deltamethrin in the cerebral tissue, April 2016, Dove Medical Press,
DOI: 10.2147/ndt.s104011.
You can read the full text:

Read
Open access logo

Contributors

The following have contributed to this page